Cognitive profiles for early diagnosis of Dementia with Lewy bodies (DLB) have been outlined in a new study, out today in ...

Lisa Ricciardi, president and CEO of Cognition Therapeutics was recently a guest on Benzinga's All-Access. Cognition ...

This specifically involved distinguishing between Alzheimer's disease, the most common form of dementia, and Lewy body ...

Research reveals sex-specific free-carnitine deficiency in women with cognitive impairment, linking mitochondrial metabolism ...

The focus was on differentiating between Alzheimer's disease, the most prevalent form of dementia, and Lewy body dementia ...

Cognitive profiles for early diagnosis of Dementia with Lewy bodies (DLB) have been outlined in a new study, out today in Alzheimer’s & Dementia. Although DLB is the second most common ...

The way in which we walk might hold the key to diagnosing Alzheimer's, or other types of dementia. Ground-breaking research ...

Among the key findings, age at diagnosis emerged as the strongest predictor of survival time. For women diagnosed at age 60, ...

Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, announced that CEO Lisa Ricciardi will be ...

Revised guidelines for amyloid and tau positron emission tomography for Alzheimer’s disease and dementia state these tests ...